Skip to main content
SCI logo

SCI — Investor Relations & Filings

Ticker · 4119 ISIN · TW0004119003 TW Manufacturing
Filings indexed 1,697 across all filing types
Latest filing 2023-02-08 Regulatory Filings
Country TW Taiwan
Listing TW 4119

SCI Pharmtech, Inc. specializes in the research, development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and specialty chemicals. Established in 1987 and originally founded by the Swiss Siegfried Group, the company provides high-quality chemical solutions and custom manufacturing services to leading global pharmaceutical corporations across Europe, North America, and Japan. Its core operations encompass advanced chemical synthesis, process optimization, and large-scale production within GMP-compliant facilities. With a robust R&D infrastructure including specialized laboratories and pilot plants, the company delivers technical excellence in complex chemical processing. SCI Pharmtech maintains a strong focus on quality assurance and international regulatory compliance, positioning itself as a reliable partner for the global healthcare and life sciences sectors.

Recent filings

Filing Released Lang Actions
112年1月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, showing zero balances for fund loans and endorsements/guarantees for the current and previous months. It contains no detailed financial statements, no management discussion, no audit information, and no regulatory certifications. The content is a straightforward regulatory disclosure of financial status related to loans and guarantees, typical of a regulatory filing or compliance announcement. The document length is very short (601 characters), and it does not present a full report or detailed financial data. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2023-02-08 Chinese
112年1月營業收入
Fund Information / Factsheet Classification · 95% confidence The document is a brief financial summary report showing monthly and cumulative net operating revenue figures for a company named 旭富 for January 2023 (民國112年01月). It includes percentage changes compared to the previous year and explanatory notes about accounting standards and reporting requirements. The document length is only 764 characters, which is very short and contains no detailed financial statements or comprehensive analysis. It is essentially a summarized revenue report, typical of a Fund Information / Factsheet (FS) or a brief financial summary. It is not an Annual Report, Interim Report, or Earnings Release because it lacks detailed financial data and analysis. It is not an announcement of a report publication or regulatory filing either, as it contains actual summarized financial data. Therefore, the best fit is Fund Information / Factsheet (FS).
2023-02-08 Chinese
112年01月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings of insiders, including directors, managers, and their related parties. It shows changes in shareholdings, stock types, and other related information. The content is focused on insider share transactions and holdings, not on financial results, management changes, or other report types. There is no indication of it being a full annual report, earnings release, or other financial report. The document is not a short announcement but a detailed disclosure of insider shareholdings. This matches the definition of Director's Dealing (DIRS), which reports personal share transactions by company directors and executives (insider trades).
2023-02-08 Chinese
112年01月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tabular data about shareholdings of company insiders, including directors, managers, and major shareholders. It lists current holdings, pledged shares, and related party holdings. The content is focused on insider share ownership and changes, which aligns with reporting of personal share transactions by company directors and executives. There is no indication of financial results, meeting materials, or regulatory announcements unrelated to insider dealings. The document length is under 5,000 characters and is a direct disclosure of insider shareholdings rather than an announcement or a report publication. Therefore, the most appropriate classification is Director's Dealing (DIRS).
2023-02-08 Chinese
111年12月營業收入
Interim / Quarterly Report Classification · 95% confidence The document is a summarized revenue report for a company named 旭富, showing monthly and cumulative net operating revenue figures with percentage changes compared to the previous year. It includes notes explaining the accounting standards and reporting requirements. The document length is short (772 characters) and it primarily provides financial data for a specific month and year (December 111 in the Taiwanese calendar, corresponding to 2022). This is a periodic financial report with actual financial figures and analysis of revenue changes, fitting the definition of an Interim / Quarterly Report (IR). It is not an announcement or a brief summary but contains substantive financial data for a period shorter than a full fiscal year.
2023-01-09 Chinese
111年12月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company (旭富) reporting on the status of fund loans and endorsement guarantees for the current and previous month, including cumulative amounts and limits. It contains no detailed financial statements or analysis, but rather a summary of specific financial risk exposures. The document length is very short (601 characters), and it does not present a full report but rather a regulatory disclosure of financial guarantees and loans. This type of document fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other categories.
2023-01-09 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.